Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain

Journal of Neurochemistry

Volumn 73, Issue 4, 1999, Pages 1660-1666

  Gabbita, S Prasad ^a   Aksenov, Michael Y ^a,b   Lovell, Mark A ^a,b   Markesbery, William R ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Methionine sulfoxide; Oxidative stress; Peptide methionine sulfoxide reductase; Reactive oxygen species

Indexed keywords

BRAIN ENZYME; CARBONYL DERIVATIVE; MESSENGER RNA; METHIONINE; METHIONINE SULFOXIDE; METHIONINE SULFOXIDE REDUCTASE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; OXIDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; RNA TRANSLATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; FEMALE; HUMANS; MALE; OXIDOREDUCTASES; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0032823578     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0731660.x     Document Type: Article

References (43)

1. Aksenov M. Y., Aksenova M. V., Payne R. M., Smith C. D., Markesbery W. R., and Carney J. M. (1997) The expression of creatine kinase isoenzymes in neocortex of patients with neurodegenerative disorders: Alzheimer's and Pick's disease. Exp. Neurol. 146, 458-465.
2. Beal M. F. (1994) Energy, oxidative damage, and Alzheimer's disease: clues to the underlying puzzle. Neurobiol. Aging 15, S171-S174.
3. Berlett B. S. and Stadtman E. R. (1997) Protein oxidation in aging, disease, and oxidative stress. J. Biol Chem. 272, 20313-20316.
4. Brot N. and Weissbach H. (1983) Biochemistry and physiological role of methionine sulfoxide residues in proteins. Arch. Biochem. Biophys. 223, 271-281.
5. Brot N., Werth J., Koster D., and Weissbach H. (1982) Reduction of N-acetyl methionine sulfoxide: a simple assay for peptide methionine sulfoxide reductase. Anal. Biochem. 122, 291-294.
6. Burbaeva G. S., Aksenova M. V., and Makarenko I. G. (1992) Decreased level of creatine kinase BB in the frontal cortex of Alzheimer patients. Dementia 3, 91-94.
7. Carp H., Miller F., Hoidal J. R., and Janoff A. (1982) Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity. Proc. Natl. Acad. Sci. USA 79, 2041-2045.
8. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
9. Ciorba M. A., Heinemann S. H., Weissbach H., Brot N., and Hoshi T. (1997) Modulation of potassium channel function by methionine oxidation and reduction. Proc. Natl. Acad. Sci. USA 94, 9932-9937.
10. Crapper-McLachlan D. R., Lukiw W. J., Wong L., Bergeron C., and Bech-Hansen N. T. (1988) Selective messenger RNA reduction in Alzheimer's disease. Mol. Brain Res. 15, 681-690.
11. Gabbita S. P., Lovell M. A., and Markesbery W. R. (1998) Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J. Neurochem. 71, 2034-2040.
12. Good P. F., Werner P., Hsu A., Olanow C. W., and Perl D. P. (1996) Evidence of neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149, 21-28.
13. Guillemette J. G., Wong L., Crapper-McLachlan D. R., and Lewis P. N. (1986) Characterization of messenger RNA from the cerebral cortex of control and Alzheimer-afflicted brain. J. Neurochem. 47, 987-997.
14. Hensley K., Hall N. C., Subramaniam R., Cole P., Harris M., Aksenov M. Y., Aksenova M. V., Gabbita S. P., Wu J. F., Carney J. M., Lovell M. A., Markesbery W. R., and Butterfield D. A. (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65, 2146-2156.
15. Hensley K., Maidt M. L., Yu Z., Sang H., Markesbery W. R., and Floyd R. A. (1998) Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J. Neurosci. 18, 8126-8132.
16. Levine R. L., Mosoni L., Berlett B. S., and Stadtman E. R. (1996) Methionine residues as endogenous antioxidants in proteins. Proc. Natl. Acad. Sci. USA 93, 15036-15040.
17. Lovell M. A., Ehmann W. D., Butler S. M., and Markesbery W. R. (1995) Elevated thiobarbituric acid-reactive substances and anti-oxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45, 1594-1601.
18. Lovell M. A., Ehmann W. D., Mattson M. P., and Markesbery W. R. (1997) Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging 18, 457-461.
19. Lovell M. A., Gabbita S. P., and Markesbery W. R. (1999) Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF. J. Neurochem. 72, 771-776.
20. Lyras L., Cairns N. J., Jenner A., Jenner P., and Halliwell B. (1997) An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68, 2061-2069.
21. Maniatis T., Fritsch E. F., and Sambrook J. (1982) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
22. Markesbery W. R. (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23, 134-147.
23. Markesbery W. R. and Camey J. M. (1999) Oxidative alterations in Alzheimer's disease. Brain Pathol. 9, 133-146.
24. Markesbery W. R. and Lovell M. A. (1998) Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging 19, 33-36.
25. McKhann G. D., Drachman D. A., Folstein M. F., Katzman R., Price D., and Stadlan E. M. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944.
26. Mecocci P., MacGarvey U., and Beal M. F. (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36, 747-751.
27. 2-isoprostane levels are increased in Alzheimer's disease. Ann. Neurol. 44, 410-413.
28. Moskovitz J., Jenkins N. A., Gilbert D. J., Copeland N. G., Jursky F., Weissbach H., and Brot N. (1996a) Chromosomal localization of the mammalian peptide-methionine sulfoxide reductase gene and its differential expression in various tissues. Proc. Natl. Acad. Sci. USA 93, 3205-3208.
29. Moskovitz J., Weissbach H., and Brot N. (1996b) Cloning and expression of a mammalian gene involved in the reduction of methionine sulfoxide residues in proteins. Proc. Natl. Acad. Sci. USA 93, 2095-2099.
30. Moskovitz J., Flescher E., Berlett B. S., Azare J., Poston J. M., and Stadtman E. R. (1998) Overexpression of peptide-methionine sulfoxide reductase in Saccharomyces cerevisiae and human T cells provides them with high resistance to oxidative stress. Proc. Natl. Acad. Sci. USA 95, 14071-14075.
31. National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol. Aging 18, S1-S2.
32. Oliver C. N., Starke-Reed P. E., Stadtman E. R., Liu G. J., Carney J. M., and Floyd R. A. (1990) Oxidative damage to brain proteins, loss of glutamine synthetase activity and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc. Natl. Acad. Sci. USA 87, 5144-5147.
33. Paik W. K. and Kim S. (1975) Protein methylation: chemical, enzymological, and biological significance. Adv. Enzymol. Relat. Areas Mol. Biol. 42, 227-286.
34. Prasad M. R., Lovell M. A., Yatin M., Dhillon H., and Markesbery W. R. (1998) Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 23, 81-88.
35. Roberts L. J., Montine T. J., Markesbery W. R., Tapper A. R., Hardy P., Chemtob S., Dettbarn W. D., and Morrow J. D. (1998) Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem. 273, 13605-13612.
36. Sajdel-Sulkowska E. M. and Marotta C. A. (1984) Alzheimer's disease brain: alterations in RNA levels and in a ribonuclease-inhibitor complex. Science 225, 947-949.
37. Smith C. D., Starke-Reed P., Oliver C. N., Stadtman E. R., Carney J. M., and Markesbery W. R. (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer's disease. Proc. Natl. Acad. Sci. USA 88, 10540-10543.
38. Smith M. A., Sayre L. M., Monnier V. M., and Perry G. (1995) Radical AGEing in Alzheimer's disease. Trends Neurosci. 18, 172-176.
39. Smith M. A., Perry G., Richey P. L., Sayre L. M., Anderson V. E., Beal M. F., and Kowall N. (1996) Oxidative damage in Alzheimer's. Nature 382, 120-121.
40. Stadtman E. R. (1992) Protein oxidation and aging. Science 257, 1220-1224.
41. Subbarao K. V., Richardson J. S., and Ang L. C. (1990) Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J. Neurochem. 55, 342-345.
42. Swaim M. W. and Pizzo S. V. (1988) Methionine sulfoxide and the oxidative regulation of plasma proteinase inhibitors. J. Leukoc. Biol. 43, 365-379.
43. Vogt W. (1995) Oxidation of methionyl residues in proteins: tools, targets, and reversal. Free Radic. Biol. Med. 18, 93-105.